In studies conducted by Summers et al. in 2010 it was shown that TLR9 is involved in the pathogenesis of SLE in a mouse model and could be a potential target in alleviating kidney damage in the early stages of the disease [29]. The gene discussed is TLR9; the disease is systemic lupus erythematosus.